← Evidence map

ArticleOncotarget2017

Gene editing of the extra domain A positive fibronectin in various tumors, amplified the effects of CRISPR/Cas system on the inhibition of tumor progression.

Wan-Qi Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2017
2018
2019
2020
2021
2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 29285230